Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A0A3Q8I9L5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 134 | 138 | PF00082 | 0.604 |
CLV_PCSK_SKI1_1 | 70 | 74 | PF00082 | 0.599 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.468 |
DOC_CKS1_1 | 85 | 90 | PF01111 | 0.405 |
DOC_MAPK_MEF2A_6 | 24 | 33 | PF00069 | 0.549 |
DOC_MAPK_MEF2A_6 | 298 | 307 | PF00069 | 0.468 |
DOC_MAPK_NFAT4_5 | 298 | 306 | PF00069 | 0.472 |
DOC_PP1_RVXF_1 | 147 | 154 | PF00149 | 0.504 |
DOC_PP1_RVXF_1 | 62 | 68 | PF00149 | 0.499 |
DOC_PP2B_LxvP_1 | 180 | 183 | PF13499 | 0.529 |
DOC_PP4_FxxP_1 | 247 | 250 | PF00568 | 0.518 |
DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.610 |
DOC_USP7_MATH_1 | 234 | 238 | PF00917 | 0.762 |
DOC_USP7_MATH_1 | 254 | 258 | PF00917 | 0.317 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.561 |
DOC_USP7_UBL2_3 | 137 | 141 | PF12436 | 0.609 |
DOC_WW_Pin1_4 | 104 | 109 | PF00397 | 0.543 |
DOC_WW_Pin1_4 | 228 | 233 | PF00397 | 0.776 |
DOC_WW_Pin1_4 | 262 | 267 | PF00397 | 0.473 |
DOC_WW_Pin1_4 | 84 | 89 | PF00397 | 0.418 |
LIG_14-3-3_CanoR_1 | 221 | 225 | PF00244 | 0.718 |
LIG_14-3-3_CanoR_1 | 24 | 31 | PF00244 | 0.439 |
LIG_14-3-3_CanoR_1 | 43 | 47 | PF00244 | 0.298 |
LIG_14-3-3_CanoR_1 | 62 | 68 | PF00244 | 0.315 |
LIG_Actin_WH2_2 | 248 | 265 | PF00022 | 0.445 |
LIG_FHA_1 | 177 | 183 | PF00498 | 0.578 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.485 |
LIG_FHA_2 | 214 | 220 | PF00498 | 0.769 |
LIG_FHA_2 | 262 | 268 | PF00498 | 0.536 |
LIG_FHA_2 | 314 | 320 | PF00498 | 0.530 |
LIG_LIR_Apic_2 | 82 | 88 | PF02991 | 0.434 |
LIG_LIR_Gen_1 | 174 | 183 | PF02991 | 0.446 |
LIG_LIR_Gen_1 | 319 | 325 | PF02991 | 0.618 |
LIG_LIR_Gen_1 | 35 | 44 | PF02991 | 0.434 |
LIG_LIR_Nem_3 | 15 | 19 | PF02991 | 0.413 |
LIG_LIR_Nem_3 | 174 | 180 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 26 | 31 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 319 | 325 | PF02991 | 0.660 |
LIG_LIR_Nem_3 | 35 | 39 | PF02991 | 0.209 |
LIG_LIR_Nem_3 | 53 | 59 | PF02991 | 0.371 |
LIG_LYPXL_yS_3 | 28 | 31 | PF13949 | 0.541 |
LIG_SH2_CRK | 36 | 40 | PF00017 | 0.490 |
LIG_SH2_CRK | 44 | 48 | PF00017 | 0.543 |
LIG_SH2_CRK | 60 | 64 | PF00017 | 0.327 |
LIG_SH2_CRK | 85 | 89 | PF00017 | 0.439 |
LIG_SH2_NCK_1 | 36 | 40 | PF00017 | 0.497 |
LIG_SH2_SRC | 58 | 61 | PF00017 | 0.516 |
LIG_SH2_STAP1 | 19 | 23 | PF00017 | 0.489 |
LIG_SH2_STAP1 | 50 | 54 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 186 | 189 | PF00017 | 0.533 |
LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.475 |
LIG_SH2_STAT5 | 44 | 47 | PF00017 | 0.458 |
LIG_SH2_STAT5 | 56 | 59 | PF00017 | 0.378 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.490 |
LIG_SH3_3 | 192 | 198 | PF00018 | 0.536 |
LIG_WRC_WIRS_1 | 239 | 244 | PF05994 | 0.508 |
MOD_CK1_1 | 145 | 151 | PF00069 | 0.574 |
MOD_CK1_1 | 223 | 229 | PF00069 | 0.755 |
MOD_CK1_1 | 311 | 317 | PF00069 | 0.438 |
MOD_CK1_1 | 37 | 43 | PF00069 | 0.446 |
MOD_CK2_1 | 214 | 220 | PF00069 | 0.691 |
MOD_CK2_1 | 261 | 267 | PF00069 | 0.452 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.716 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.718 |
MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.470 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.516 |
MOD_GlcNHglycan | 291 | 294 | PF01048 | 0.391 |
MOD_GlcNHglycan | 313 | 316 | PF01048 | 0.475 |
MOD_GlcNHglycan | 35 | 39 | PF01048 | 0.457 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.565 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.447 |
MOD_GSK3_1 | 186 | 193 | PF00069 | 0.504 |
MOD_GSK3_1 | 228 | 235 | PF00069 | 0.787 |
MOD_GSK3_1 | 254 | 261 | PF00069 | 0.517 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.430 |
MOD_NEK2_1 | 111 | 116 | PF00069 | 0.568 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.621 |
MOD_NEK2_1 | 286 | 291 | PF00069 | 0.555 |
MOD_NEK2_1 | 305 | 310 | PF00069 | 0.319 |
MOD_NEK2_1 | 42 | 47 | PF00069 | 0.447 |
MOD_PIKK_1 | 127 | 133 | PF00454 | 0.588 |
MOD_PIKK_1 | 186 | 192 | PF00454 | 0.568 |
MOD_PIKK_1 | 220 | 226 | PF00454 | 0.718 |
MOD_PKA_2 | 220 | 226 | PF00069 | 0.718 |
MOD_PKA_2 | 23 | 29 | PF00069 | 0.451 |
MOD_PKA_2 | 42 | 48 | PF00069 | 0.298 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.476 |
MOD_Plk_1 | 142 | 148 | PF00069 | 0.573 |
MOD_Plk_1 | 171 | 177 | PF00069 | 0.560 |
MOD_Plk_1 | 34 | 40 | PF00069 | 0.365 |
MOD_Plk_1 | 68 | 74 | PF00069 | 0.556 |
MOD_Plk_4 | 176 | 182 | PF00069 | 0.538 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.389 |
MOD_ProDKin_1 | 104 | 110 | PF00069 | 0.540 |
MOD_ProDKin_1 | 228 | 234 | PF00069 | 0.772 |
MOD_ProDKin_1 | 262 | 268 | PF00069 | 0.472 |
MOD_ProDKin_1 | 84 | 90 | PF00069 | 0.409 |
MOD_SUMO_for_1 | 140 | 143 | PF00179 | 0.610 |
TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.533 |
TRG_ENDOCYTIC_2 | 281 | 284 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 36 | 39 | PF00928 | 0.397 |
TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.456 |
TRG_ER_diArg_1 | 62 | 65 | PF00400 | 0.466 |
TRG_NES_CRM1_1 | 2 | 15 | PF08389 | 0.555 |
TRG_PTS1 | 322 | 325 | PF00515 | 0.644 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I141 | Leptomonas seymouri | 59% | 100% |
A0A1X0NNS3 | Trypanosomatidae | 40% | 100% |
A4H748 | Leishmania braziliensis | 86% | 100% |
A4HVI8 | Leishmania infantum | 98% | 100% |
D0A6R7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
E9AP83 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4QG95 | Leishmania major | 95% | 100% |
V5BJY4 | Trypanosoma cruzi | 38% | 100% |